Weigao $300m IPO sees delay as sponsor leaves

Shandong Weigao Orthopaedic Device Company has put its $300m IPO in Hong Kong on hold after Morgan Stanley, one its joint sponsors, allegedly dropped out as a lead banker, potentially delaying the listing by at least a few weeks.... more

APAC Financial Markets • #CICC, #Delay, #Equities, #HongKong, #IPO, #MorganStanley, #ShandongWeigaoOrthopaedicDevice, #UBS #Equities, #Issuance/Pipeline

3SBio nets $712m as IPO prices at the top

3SBio hit it out of the park with its Hong Kong IPO, pricing shares at the top of expectations as hundreds of accounts poured into the HK$5.51bn ($712m) trade, and bankers lamented that those who got zeroed were “too many to count”.... more

APAC Financial Markets • #3SBio, #CiticSecuritiesInternational, #Equities, #GoldmanSachs, #HongKong, #IPO, #MorganStanley #Equities, #Issuance/Pipeline